Back to School: How biopharma can reboot drug development. Access exclusive analysis here
INDICATION: Lung cancer
Patient sample, cell culture and mouse studies suggest inhibiting KMT5A could help treat lung squamous cell carcinoma
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury